ImmuCell Corporation Revenue from Related Parties
ImmuCell Corporation (ICCC) reported Revenue from Related Parties of $587.68 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Income Statement › Other Income
us-gaap:RevenueFromRelatedParties · last filed 2023-03-29
- ImmuCell Corporation revenue from related parties for the quarter ending 2022-12-31 was $87.66K, a 62.16% decline year-over-year.
- ImmuCell Corporation revenue from related parties for the quarter ending 2022-09-30 was $142.29K, a 41.41% increase year-over-year.
- ImmuCell Corporation revenue from related parties for the quarter ending 2022-06-30 was $130.89K, a 36.72% decline year-over-year.
- ImmuCell Corporation revenue from related parties for the quarter ending 2022-03-31 was $226.83K, a 101.99% increase year-over-year.
- ImmuCell Corporation revenue from related parties for fiscal 2022 was $587.68K, a 9.79% decline from fiscal 2021.
- ImmuCell Corporation revenue from related parties for fiscal 2021 was $651.42K, a 2.53% decline from fiscal 2020.
- ImmuCell Corporation revenue from related parties for fiscal 2020 was $668.31K, a 36.30% increase from fiscal 2019.
- ImmuCell Corporation revenue from related parties for fiscal 2019 was $490.32K, a 7.10% decline from fiscal 2018.
| Period end | Revenue from Related Parties 3 month | Revenue from Related Parties 6 month | Revenue from Related Parties 6 month as first filed | Revenue from Related Parties 9 month | Revenue from Related Parties 9 month as first filed | Revenue from Related Parties 12 month |
|---|---|---|---|---|---|---|
| 2022-12-31 | $87.66K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $229.95K derived: sum of 2 quarters · filed 2023-03-29 | $360.84K derived: sum of 3 quarters · filed 2023-03-29 | $587.68K 10-K · filed 2023-03-29 | ||
| 2022-09-30 | $142.29K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $273.18K derived: sum of 2 quarters · filed 2022-11-21 | $500.01K 10-Q · filed 2022-11-21 | $731.68K derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2022-06-30 | $130.89K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-11-21 | $357.73K 10-Q/A · filed 2022-11-21 | $589.39K derived: sum of 3 quarters · filed 2023-03-29 | $690.02K derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2022-03-31 | $226.83K 10-Q/A · filed 2022-11-21 | $458.50K derived: sum of 2 quarters · filed 2023-03-29 | $559.12K derived: sum of 3 quarters · filed 2023-03-29 | $765.96K derived: sum of 4 quarters · filed 2023-03-29 | ||
| 2021-12-31 | $231.67K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $332.29K derived: sum of 2 quarters · filed 2023-03-29 | $539.12K derived: sum of 3 quarters · filed 2023-03-29 | $651.42K 10-K · filed 2023-03-29 | ||
| 2021-09-30 | $100.62K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $307.45K derived: sum of 2 quarters · filed 2022-11-21 | $419.75K 10-Q · filed 2022-11-21 | $552.61K derived: sum of 4 quarters · filed 2022-11-21 | ||
| 2021-06-30 | $206.83K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-11-21 | $319.13K 10-Q/A · filed 2022-11-21 | $451.98K derived: sum of 3 quarters · filed 2022-11-21 | $573.13K derived: sum of 4 quarters · filed 2022-11-21 | ||
| 2021-03-31 | $112.30K 10-Q/A · filed 2022-11-21 | $245.15K derived: sum of 2 quarters · filed 2022-11-21 | $366.30K derived: sum of 3 quarters · filed 2022-11-21 | $515.78K derived: sum of 4 quarters · filed 2022-11-21 | ||
| 2020-12-31 | $132.85K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $254.00K derived: sum of 2 quarters · filed 2022-03-30 | $403.48K derived: sum of 3 quarters · filed 2022-03-30 | $668.31K 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $121.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $270.63K derived: sum of 2 quarters · filed 2021-11-15 | $535.46K 10-Q · filed 2021-11-15 | $631.90K derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $149.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $414.31K 10-Q · filed 2021-08-12 | $510.75K derived: sum of 3 quarters · filed 2021-08-12 | $614.05K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $264.83K 10-Q · filed 2021-05-13 | $361.27K derived: sum of 2 quarters · filed 2021-05-13 | $464.57K derived: sum of 3 quarters · filed 2021-05-13 | $578.29K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $96.44K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $199.74K derived: sum of 2 quarters · filed 2021-03-30 | $313.46K derived: sum of 3 quarters · filed 2021-03-30 | $490.32K 10-K · filed 2021-03-30 | ||
| 2019-09-30 | $103.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $217.01K derived: sum of 2 quarters · filed 2020-11-12 | $393.88K 10-Q · filed 2020-11-12 | $529.39K derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | $113.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $290.58K 10-Q · filed 2020-08-12 | $426.09K derived: sum of 3 quarters · filed 2020-08-12 | $481.33K derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2019-03-31 | $176.87K 10-Q · filed 2020-05-13 | $312.38K derived: sum of 2 quarters · filed 2020-05-13 | $367.62K derived: sum of 3 quarters · filed 2020-05-13 | $495.05K derived: sum of 4 quarters · filed 2020-05-13 | ||
| 2018-12-31 | $135.51K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $190.75K derived: sum of 2 quarters · filed 2020-03-27 | $318.19K derived: sum of 3 quarters · filed 2020-03-27 | $527.82K 10-K · filed 2020-03-27 | ||
| 2018-09-30 | $55.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $182.68K derived: sum of 2 quarters · filed 2019-11-12 | $392.31K 10-Q · filed 2019-11-12 | $536.71K derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $127.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $337.06K 10-Q · filed 2019-08-12 | $481.47K derived: sum of 3 quarters · filed 2019-08-12 | $611.79K derived: sum of 4 quarters · filed 2019-08-12 | ||
| 2018-03-31 | $209.63K 10-Q · filed 2019-05-13 | $354.04K derived: sum of 2 quarters · filed 2019-05-13 | $484.36K derived: sum of 3 quarters · filed 2019-05-13 | $623.00K derived: sum of 4 quarters · filed 2019-05-13 | ||
| 2017-12-31 | $144.40K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $274.72K derived: sum of 2 quarters · filed 2019-03-22 | $413.37K derived: sum of 3 quarters · filed 2019-03-22 | $610.07K 10-K · filed 2019-03-22 | ||
| 2017-09-30 | $130.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $268.96K derived: sum of 2 quarters · filed 2018-11-13 | $465.67K 10-Q · filed 2018-11-13 | $540.38K derived: sum of 4 quarters · filed 2018-11-13 | ||
| 2017-06-30 | $138.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $335.35K 10-Q · filed 2018-08-13 | $410.06K derived: sum of 3 quarters · filed 2018-08-13 | $554.42K derived: sum of 4 quarters · filed 2018-08-13 | ||
| 2017-03-31 | $196.71K 10-Q · filed 2018-05-14 | $271.42K derived: sum of 2 quarters · filed 2018-05-14 | $415.78K derived: sum of 3 quarters · filed 2018-05-14 | $589.34K derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | $74.71K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $219.07K derived: sum of 2 quarters · filed 2018-03-29 | $392.63K derived: sum of 3 quarters · filed 2018-03-29 | $551.02K 10-K · filed 2018-03-29 | ||
| 2016-09-30 | $144.37K 10-Q · filed 2016-11-10 | $317.92K derived: sum of 2 quarters · filed 2017-08-14 | $476.31K 10-Q · filed 2017-11-13 | $597.27K derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-06-30 | $173.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $331.95K 10-Q · filed 2017-08-14 | $452.90K derived: sum of 3 quarters · filed 2017-08-14 | $610.25K derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $158.39K 10-Q · filed 2017-05-11 | $279.35K derived: sum of 2 quarters · filed 2017-05-11 | $436.69K derived: sum of 3 quarters · filed 2017-05-11 | $538.91K derived: sum of 4 quarters · filed 2017-05-11 | ||
| 2015-12-31 | $120.96K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $278.31K derived: sum of 2 quarters · filed 2017-03-30 | $380.52K derived: sum of 3 quarters · filed 2017-03-30 | $573.16K 10-K · filed 2017-03-30 | ||
| 2015-09-30 | $157.35K 10-Q · filed 2016-11-10 | $259.56K derived: sum of 2 quarters · filed 2016-11-10 | $452.21K 10-Q · filed 2016-11-10 | $595.28K derived: sum of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | $102.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $294.86K 10-Q · filed 2016-08-11 | $437.93K derived: sum of 3 quarters · filed 2016-08-11 | $506.82K derived: sum of 4 quarters · filed 2016-08-11 | ||
| 2015-03-31 | $192.64K 10-Q · filed 2016-05-11 | $335.71K derived: sum of 2 quarters · filed 2016-05-11 | $404.61K derived: sum of 3 quarters · filed 2016-05-11 | $493.23K derived: sum of 4 quarters · filed 2016-05-11 | ||
| 2014-12-31 | $143.07K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $211.97K derived: sum of 2 quarters · filed 2016-03-25 | $300.59K derived: sum of 3 quarters · filed 2016-03-25 | $426.36K 10-K · filed 2016-03-25 | ||
| 2014-09-30 | $68.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $157.52K derived: sum of 2 quarters · filed 2015-11-12 | $283.29K 10-Q · filed 2015-11-12 | $389.97K derived: sum of 4 quarters · filed 2016-03-25 | ||
| 2014-06-30 | $88.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $214.39K 10-Q · filed 2015-08-13 | $321.07K derived: sum of 3 quarters · filed 2016-03-25 | $398.64K derived: sum of 4 quarters · filed 2016-03-25 | ||
| 2014-03-31 | $125.77K 10-Q · filed 2015-05-12 | $232.45K derived: sum of 2 quarters · filed 2016-03-25 | $310.02K derived: sum of 3 quarters · filed 2016-03-25 | $416.28K derived: sum of 4 quarters · filed 2016-03-25 | ||
| 2013-12-31 | $106.68K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $184.25K derived: sum of 2 quarters · filed 2016-03-25 | $290.51K derived: sum of 3 quarters · filed 2016-03-25 | $395.04K 10-K · filed 2016-03-25 | ||
| 2013-09-30 | $77.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $183.83K derived: sum of 2 quarters · filed 2014-11-12 | $288.36K 10-Q · filed 2014-11-12 | $393.77K derived: sum of 4 quarters · filed 2015-03-26 | ||
| 2013-06-30 | $106.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $210.79K 10-Q · filed 2014-08-13 | $316.20K derived: sum of 3 quarters · filed 2015-03-26 | $403.89K derived: sum of 4 quarters · filed 2015-03-26 | ||
| 2013-03-31 | $104.53K 10-Q · filed 2014-05-14 | $209.94K derived: sum of 2 quarters · filed 2015-03-26 | $297.63K derived: sum of 3 quarters · filed 2015-03-26 | |||
| 2012-12-31 | $105.41K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $193.10K derived: sum of 2 quarters · filed 2015-03-26 | $326.51K 10-K · filed 2015-03-26 | |||
| 2012-09-30 | $87.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $221.10K 10-Q · filed 2013-11-13 | $220.60K 10-Q · filed 2012-11-13 | |||
| 2012-06-30 | $133.42K 10-Q · filed 2013-08-13 | $133.00K 10-Q/A · filed 2012-09-07 | ||||
| 2011-12-31 | $81.25K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $156.16K derived: sum of 2 quarters · filed 2014-03-26 | $295.16K 10-K · filed 2014-03-26 | |||
| 2011-09-30 | $74.91K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $213.91K 10-Q · filed 2012-11-13 | ||||
| 2011-06-30 | $139.00K 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |